Trending...
- Harborside Senior Living CEO Making Assisted Living More Affordable in Monroe County Ask About Up to $25K in Annual Care Support - 138
- Macomb Township Chiropractic Helps Teen Return To Wrestling Patient After Back, Hip, and Neck Injuries - 125
- Oral statement on the situation of Chairman Lee Man-hee in pretrial detention in the Republic of Korea - 124
This Approval Allows MedWand to Enhance Efficiency, Convenience, and Access to Care in Thailand
RANCHO SANTA MARGARITA, Calif. - Michimich -- MedWand Solutions, Inc., the ultimate healthcare solution and a pioneer in telehealth technology, is pleased to announce its recent regulatory clearance in Thailand. This latest approval allows MedWand to empower a broader spectrum of clinicians and healthcare providers, enabling them to elevate care standards and grant easier access to healthcare services.
"The regulatory clearance in Thailand reflects our dedication to making comprehensive remote healthcare services accessible worldwide," shared MedWand Senior Director of International Business Development, Stuart English. "We are thrilled to bring MedWand to Thailand, addressing healthcare needs and creating new opportunities for collaboration with international partners."
More on Michimich.com
MedWand is the ultimate healthcare solution, seamlessly integrating traditional tools and Bluetooth connectivity for vitals capture and remote patient evaluations to enhance efficiency, convenience, and access to care. Following its FDA clearance and product launch in the United States in 2022, MedWand has gained significant traction with major US health systems, telehealth companies, large private practices, and employers.
"Following thorough research, we have identified the MedWand multi-sensor vitals capture device, together with the VirtualCare telemedicine platform, as the pivotal components essential for revolutionizing telemedicine services. This combination is poised to facilitate advanced clinical care accessible to patients regardless of their location, eliminating the necessity for hospital visits," commented Dr. Supornchai Kongpatanakul, President of Kitmeechai Trading Co., Ltd.
More on Michimich.com
The device's versatility and ease of use make it a valuable asset for both healthcare professionals and patients. Transforming the traditional understanding of telehealth, MedWand combines multiple vitals sensors into one, handheld, lightweight device. Data collected can include core temperature, blood oxygen saturation, and pulse rate, heart, lung and abdominal auscultations, electrocardiogram*, and high definition otoscopic, oropharynx, and dermatoscopic exam images. Through approved 3rd party Bluetooth peripherals, MedWand can also seamlessly capture blood pressure, glucometer, spirometry, and weight data.
For more information on MedWand visit www.medwand.com. To schedule a private demonstration or to request a formal quotation please contact MedWand at https://www.medwandhealth.com/contact.
*Electrocardiogram feature is currently awaiting US FDA 510(k) clearance.
"The regulatory clearance in Thailand reflects our dedication to making comprehensive remote healthcare services accessible worldwide," shared MedWand Senior Director of International Business Development, Stuart English. "We are thrilled to bring MedWand to Thailand, addressing healthcare needs and creating new opportunities for collaboration with international partners."
More on Michimich.com
- Pear Sperling Eggan & Daniels, P.C. Highlights the Importance of Estate Planning After Divorce
- ArborMotion Encourages Drivers to Check Wheel Alignment Before Fall
- HW Foundation Opens Nominations for Inaugural 50 Under 50 in AI; Deadline Oct. 16
- Pavillon 30 Years of Addiction Recovery in Western North Carolina, Earns National Accreditation
- Keep Your Eyes To The Sky…We Up !
MedWand is the ultimate healthcare solution, seamlessly integrating traditional tools and Bluetooth connectivity for vitals capture and remote patient evaluations to enhance efficiency, convenience, and access to care. Following its FDA clearance and product launch in the United States in 2022, MedWand has gained significant traction with major US health systems, telehealth companies, large private practices, and employers.
"Following thorough research, we have identified the MedWand multi-sensor vitals capture device, together with the VirtualCare telemedicine platform, as the pivotal components essential for revolutionizing telemedicine services. This combination is poised to facilitate advanced clinical care accessible to patients regardless of their location, eliminating the necessity for hospital visits," commented Dr. Supornchai Kongpatanakul, President of Kitmeechai Trading Co., Ltd.
More on Michimich.com
- ResC4EU Final Event at KOMPOZYT-EXPO 2026 – Building Resilient European Supply Chains
- Macomb Township Chiropractic Helps Teen Return To Wrestling Patient After Back, Hip, and Neck Injuries
- Harborside Senior Living CEO Making Assisted Living More Affordable in Monroe County Ask About Up to $25K in Annual Care Support
- CardsNearby Launches Free Nationwide Directory of Card Shows and Local Card Shops for Collectors
- Anton Williams Holding Company Announces Reformed Neo Calvinist Corporate Purpose Statement
The device's versatility and ease of use make it a valuable asset for both healthcare professionals and patients. Transforming the traditional understanding of telehealth, MedWand combines multiple vitals sensors into one, handheld, lightweight device. Data collected can include core temperature, blood oxygen saturation, and pulse rate, heart, lung and abdominal auscultations, electrocardiogram*, and high definition otoscopic, oropharynx, and dermatoscopic exam images. Through approved 3rd party Bluetooth peripherals, MedWand can also seamlessly capture blood pressure, glucometer, spirometry, and weight data.
For more information on MedWand visit www.medwand.com. To schedule a private demonstration or to request a formal quotation please contact MedWand at https://www.medwandhealth.com/contact.
*Electrocardiogram feature is currently awaiting US FDA 510(k) clearance.
Source: MedWand Solutions
Filed Under: Health
0 Comments
Latest on Michimich.com
- Infinity Infusion Solutions Launches "Women Leading Infusion Care" Campaign for National Women in Business Month
- HuskyTail Digital Puts AI to Work Behind the Scenes to Cut Client Turnaround Time
- AI, Real-World Data "RWD" and U.S. Expansion Put Predictive Healthcare in Focus for POMDOCTOR Ltd. (N A S D A Q: POM)
- $11.18 Million DARPA Award Ignites a Major New Catalyst as FDA, Robotic TMS and Commercialization Milestones Converge for NRx Pharmaceuticals, Inc
- Hidden Storm Damage Could Turn Into Winter Leaks for Homeowners
- P-Wave Classics to publish Thomas Holcroft's The Adventures of Hugh Trevor in three volumes, beginning 19 January
- Ad Leverage Sponsors ServiceTitan Pantheon 2026, Supporting Education and Growth in the Home Services Industry
- DBF Viewer 2000 v9.32 Adds New Control for Data Export
- Badanamu Partners With Moonbug Entertainment In Landmark Distribution Deal
- Nutriband (N A S D A Q: NTRB): Fighting Back Against the Fentanyl Crisis With a New Approach to Safer Transdermal Medicines
- Oral statement on the situation of Chairman Lee Man-hee in pretrial detention in the Republic of Korea
- ESPEC North America Welcomes Zeke Fuentes as Regional Sales Manager - East Coast
- Michigan Walk and Roll to School Day
- Motor City Half Marathon to Make Inaugural Detroit Debut in Spring 2027
- Names Are Not Important Asks What Remains When Identity Is Stripped of Labels
- Most Utah Deaths Never Reach the Medical Examiner. Postmortem Pathology Offers Salt Lake City a Private Autopsy Option
- Virtually Tour Heritage at South Brunswick's Resort-Style Living - Experience Indoor and Outdoor Amenities at Your Fingertips
- Derek Cook's Roofing Encourages Homeowners to Prepare for Fall Weather
- Boston Industrial Solutions Expands Product Offering with Pad Printing Pads and Silicone for Custom Pad Manufacturing
- Rodeo FX Originals Appoints Yvann Thibaudeau Head of Development & IP
